Paper · 2250705
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.
Hockenbery D and 4 others. Nature, 1990. Cited by 3,653 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Papers, record 2250705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2250705
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Survival | Major topic |
| Lymphoma | Major topic |
| Membrane Proteins | Major topic |
| Mitochondria | Major topic |
| Oncogenes | Major topic |
| Proto-Oncogene Proteins | Major topic |
| Animals | |
| Antibodies, Monoclonal | |
| Base Sequence | |
| Blotting, Western | |
| Cell Line | |
| Chromosomes, Human, Pair 14 | |
| Chromosomes, Human, Pair 18 | |
| Codon | |
| Humans | |
| Molecular Sequence Data | |
| Open Reading Frames | |
| Proto-Oncogene Proteins c-bcl-2 | |
| Translocation, Genetic |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by814
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3,653 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,882,893 | Chk1/2 Inhibition by AZD7762 Enhances Andrographolide-Induced DNA Damage, Impairs DNA Repair, and Promotes Apoptosis in Head and Neck Squamous Cell Carcinoma CAL-33 Cells. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42882893 | PubMed |
| 42,721,182 | N-acetylcysteine attenuates oxidative-stress-associated apoptosis and collagen deposition after rat hindlimb ischemia-reperfusion injury. | PLoS One | 2026 | https://conductscience.org/library/papers/42721182 | PubMed |
| 42,416,494 | Nephrotoxic acute kidney injury induced by Daboia siamensis venom and its fractions: assessment of Bcl-2 family expression in in vivo and ex vivo in rabbit models. | J Venom Anim Toxins Incl Trop Dis | 2026 | https://conductscience.org/library/papers/42416494 | PubMed |
| 42,248,141 | Xenophagocytosis blockade enhances interspecies chimerism. | Cell | 2026 | https://conductscience.org/library/papers/42248141 | PubMed |
| 42,213,242 | Regulated cell death programs shaping cancer therapy. | Cell Oncol (Dordr) | 2026 | https://conductscience.org/library/papers/42213242 | PubMed |
| 42,199,066 | Mitophagy in cisplatin-induced kidney injury: regulatory mechanisms and therapeutic targets. | Ann Med | 2026 | https://conductscience.org/library/papers/42199066 | PubMed |
| 42,084,012 | A century of cell death research. | J Cell Sci | 2026 | https://conductscience.org/library/papers/42084012 | PubMed |
| 41,929,632 | Mechanistic overview and suggested strategies to overcome BCL-2 inhibitor resistance in TP53-mutated acute myeloid leukemia. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/41929632 | PubMed |
| 41,776,400 | The caspase gene family in Micropterus salmoides: genome-wide characterization, bioinformatics, and expression profiling analysis. | BMC Genomics | 2026 | https://conductscience.org/library/papers/41776400 | PubMed |
| 41,772,680 | Methyl-cantharidimide suppresses cyclin-dependent kinase 1 (CDK1) and induces oxeiptosis in liver cancer. | J Exp Clin Cancer Res | 2026 | https://conductscience.org/library/papers/41772680 | PubMed |
1 to 10 of 814
See all 814 cited byGenes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BCL2 | 596 | Swiss-Prot's references | https://conductscience.org/library/genes/596 | NCBI Gene |
| IGHD | 3,495 | PubTator's text mining | https://conductscience.org/library/genes/3495 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2250705
GET https://conductscience.org/api/papers/v1/2250705/cited_by?page=2